NCT04458922 2026-03-17
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
ModeX Therapeutics, An OPKO Health Company
LTZ Therapeutics, Inc.
Haihe Biopharma Co., Ltd.
Eli Lilly and Company